Email Updates

Search form

You are here

Animal studies of new HIV vaccine candidate show promise

Include in
Media Coverage

A new HIV vaccine candidate that prompts what are known as broadly neutralizing antibodies against the virus has shown promise in animal research. Consequently, researchers at the National Institute of Allergy and Infectious Diseases are planning an early human trial of the vaccine candidate to begin during the second half of 2019.

June 8, 2018